Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
Advance on study of Huoxin Pills for cardiovascular diseases
Hits 537  Download times 321  Received:January 20, 2022  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2022.03.23
Key Words   Huoxin Pill;cardiovascular diseases;anti-myocardial fibrosis;anti-oxidative stress;anti-inflammatory;cardiac apoptosis
Author NameAffiliationE-mail
HUI Jiaqi Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China
Institute of Geriatrics of China Academy of Chinese Medical Sciences, Beijing 100091, China
Graduate school of China Academy of Chinese Medical Sciences, Beijing 100091, China 
 
XIN Qiqi Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China 
 
YUAN Rong Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China 
 
MIAO Yu Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China 
 
XU Fengqin National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China
Institute of Geriatrics of China Academy of Chinese Medical Sciences, Beijing 100091, China 
doctorxu@aliyun.com 
CONG Weihong Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China 
congcao@188.com 
Abstract
    Cardiovascular diseases(CVDs) belong to the category of "heart disease syndrome" in traditional Chinese medicine. The high prevalence and mortality rate of CVDs caused a huge social burden. Traditional Chinese medicine has efficient therapeutic functions on various types of CVDs. Huoxin Pill which plays an important role in enriching qi and activating blood, warming and activating meridian, has been extensively used in CVDs such as angina pectoris. Clinical and basic researches during the past 5 years have shown that Huoxin Pill has a certain role in improving cardiac function and cardioprotective by suppressing myocardial fibrosis, oxidative stress, inflammatory, and inhibiting cardiac apoptosis. To clarify Huoxin Pill's current and potential application, this paper reviews the literature on Huoxin Pill in CVDs from the perspectives of composition, clinical applications, and pharmacological mechanisms to provide theoretical reference for intensive research.

You are the 1632240 visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.